By irradiating targets in the world-class OPAL research reactor, a diverse set of radioisotopes, primarily for nuclear medicine, are available for a variety of applications and for research.
To complement this suite of emerging, noncommercially available OPAL-produced radioisotopes, we are working to extend this range by accessing
- ANSTO commercial
- National partner cyclotrons
- Imports from international commercial radioisotope vendors
- Imports from collaborative international research reactors and accelerators
The availability of these radioisotopes will differ significantly depending on reactor and cyclotron scheduling and demand for non-routine custom irradiated products.
Fundamental to this capability, ANSTO provides well-equipped, licensed facilities and highly trained staff to handle SPECT-, PET- and therapeutically relevant radionuclides.
ANSTO also operates the National Research Cyclotron Facility providing fluorine-18 and carbon-11 for research.
Please confirm the availability of your selected radioisotope with your ANSTO contact before submitting your proposal.